Eisai Epilepsy Drug Rufinamide Is "Approvable"
The company is seeking indications to treat Lennox-Gastaut syndrome and partial-onset seizures for the new molecular entity.
The company is seeking indications to treat Lennox-Gastaut syndrome and partial-onset seizures for the new molecular entity.